
Biotech News
Alvotech and Teva Announce U.S. FDA Filing Acceptance of Biologics License Applications for AVT05
Alvotech, a global biotech company focused on biosimilars, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced that the U.S. Food and Drug Administration (FDA) has accepted their Biologics License Applications (BLAs) for AVT05. The proposed biosimilar